Key result
Wistar Furth rats were protected from chronic renal disease progression after renal mass reduction compared to Sprague Dawley rats, associated with maintained nitric oxide production.
Elevated nitric oxide production in Wistar Furth rats protects against the progression of chronic renal disease following renal mass reduction.
Answers are grounded in this paper and cite their sources.
Animal data on nitric oxide in renal ablation models should not guide practice; leaves open relevance to human CKD progression.
Wistar Furth (WF) rats do not develop renal injury after severe reduction of renal mass. Because clinical and animal studies suggested that nitric oxide (NO) deficiency occurs and may contribute to chronic renal disease (CRD), the status of the NO system in WF versus Sprague Dawley (SD) rats was examined with the 5/6 renal ablation/infarction (A/I) model of CRD. Eleven weeks after A/I, SD rats developed proteinuria, severe kidney damage, decreased renal function, and marked decreases in total and renal NO synthase (NOS), specifically neuronal NOS. In contrast, WF rats exhibited elevated baseline and maintained post-A/I total NO production, with no decrease in renal cortex NOS activity despite a decrease in remnant neuronal NOS abundance. When low-dose chronic Nomega-nitro-L-arginine methyl ester treatment was added for WF A/I-treated rats, rapid progression of CRD was observed. In conclusion, elevated NO production in WF rats was associated with protection from the progression of CRD after renal mass reduction. The protection might be attributable to greater total and renal NO-generating capacity and increased nephron number, compared with SD rats. NOS inhibition rendered WF rats susceptible to progression, suggesting a possible critical threshold for NO production, below which renal injury occurs.
No takes yet. Share an insight, caveat, or question.
Erdely et al. (2003) studied Chronic renal disease. Wistar Furth (WF) strain vs. Sprague Dawley (SD) strain was evaluated on Progression of chronic renal disease (proteinuria, kidney damage, renal function). Wistar Furth rats were protected from chronic renal disease progression after renal mass reduction compared to Sprague Dawley rats, associated with maintained nitric oxide production.
Synapse has enriched 10 related papers. Consider them for comparative context: